PORTFOLIO
Portfolio
-
NEXTGEN -
NOVELTY NOBILITY -
DAAN Biotherapeutics -
D&D Pharmatech -
RiboTech -
Regen Innopharm -
MasterMeditech -
BIORCHESTRA -
BREEZEBIO -
CELLEMEDY -
CdmoGen -
ARUM THERAPEUTICS -
IDIENCE -
iN Therapeutics -
ANTEROGEN -
AbClon -
SN BioScience -
SL Therapeutics -
FNCTBIOTECH -
Exosome Plus -
elisiGen -
ELGEN THERAPEUTICS -
MTHERA PHARMA -
Orum Therapeutics -
AUTOTAC Bio -
Ubix Therapeutics -
Eutilex -
Illimis Therapeutics -
JD Bioscience -
Gencellmed -
GI Cell -
G2GBIO -
Kanaph Therapeutics -
CARUS Bio -
CasCure Therapeutics -
Txinno Bioscience -
1ST Biotherapeutics -
HysensBio -
Celloram
DAYLI PARTNERS
201, Teheran-ro, Gangnam-gu, Seoul, Republic of Korea
Tel : +82-2-563-0890
Fax : +82-2-563-8787
E-mail : contact@dayli.partners
Copyright © 2024 DAYLI PARTNERS. ALL RIGHTS RESERVED